Bypassing immune rejection in stem cell-based therapies
In an article featured in the latest issue of STEM CELLS, a research group from Stanford University describes a novel regimen for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Family history of diabetes increases the risk of prediabetes by 26 per cent
A study involving more than 8,000 participants has shown that people with a family history of diabetes see their risk of…
Scientists from University of Strathclyde invents technology to treat major illnesses
'Shapeshifting' computer programme will open up drug discovery for tricky disease targets
Gearing up for the future
Usha Sharma seeks the views of industry stalwarts on the recent upheavals in the Indian pharma regulatory system and finds that…
‘India’s pharma sector is currently undergoing unprecedented regulatory…
The Indian regulations for pharmaceuticals are witnessing a transformation. There are several examples where small and big changes…
’All the changes will lead to better and positive growth’
In India, the pharma industry is fast changing with a new outlook at the healthcare sector. The changes are going to affect the…
’Recent regulatory changes are impacting the industry significantly’
Dr Milind Antani Pricing of drugs: The Ministry of Chemicals and Fertilizers notified the DPCO 2013 on May 15, 2013 that…
’The drugs control dept in almost every state needs a revamp’
In the recent past, the pharma Industry has seen a tremendous development after the IT revolution in India though there have been…
‘I believe that beginning 2014 will see a change in the landscape’
I feel that the recent changes in the filling requirement for abbreviated new drug applications brought about by the FDA will have…
’Indian regulatory scenario is far from rosy at these times’
I have been a firm believer and a positive thinker on Indian pharma industry and its capabilities and strengths to scale the…
‘Let this be the tipping point, but in a way that is to the benefit of all…
A year ago the impending Drug Prices Control Order (DPCO) was a key topic for debate. One year down the line the new DPCO has been…
’Game cards need to be played with lot of concentration and long-term vision’
There is definitely a transformation seen in the Indian pharma industry. Indian pharma industry is a long term player in the…
Raise your game – Expand your horizons in the Indian OTC market
Sreedevi Yallamrazu, Sr Strategic Analyst, CubeX, provides a snapshot of the dynamics of the Indian OTC market and various…
Rising above Neglect
In January last year, 13 pharmaceutical companies alongwith the US, the UK and the UAE governments; Bill & Melinda Gates…
Jubilant Biosys files IND with US-based Endo Pharmaceuticals
IND relates to a novel molecule targetting prostate cancer
DoP extends excise duty exemption on formulations under DPCO 2013
No extension in the deadlines set for price revision
World’s pharma development manufacturing base moving to India: IBEF
Generics exports growth of nearly 30 per cent enabling greater research spend
Ranbaxy allocates site for greenfield manufacturing facility in Malaysia
Agreement signed with Kulim Hi Tech Park
Biocon introduces novel biologic, ALZUMAb for psoriasis in India
ALZUMAb is being introduced in India by Biocon's Immuno Therapy Division
West-Coast Pharmaceutical Works to foray into nutraceutical segment
To launch the products in the western region of the country initially